|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Joint Diseases | |||||
| Osteoarthritis | |||||
| 2 | More general conditions related to this trial | ||||
| Arthritis | |||||
| Musculoskeletal Diseases | |||||
| Rheumatic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| 45.5% DMSO (topical placebo) | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Diclofenac | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Cyclooxygenase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Alberta, Graduate Orthodontic Program | |||||
| University of Alberta | |||||